Streetbeat News

Analyst Ratings

EPAM

Needham analyst Mayank Tandon reiterated a Buy rating on EPAM Systems, Inc. (NYSE:EPAM) but lowered the price target to $275 from $325 due to sluggish demand. EPAM has slashed its Q2 and FY23 financial outlook, with clients becoming cautious about digital transformation spending. However, Tandon believes EPAM can return to 20%+ organic revenue growth by mid to late FY24 if economic conditions improve.

Portfolio Pulse from Nabaparna Bhattacharya

June 05, 2023 | 6:16 pm

LLY

A large bearish position on Eli Lilly (NYSE:LLY) has been spotted on Benzinga's options scanner, with 70% of big-money traders showing bearish sentiment. Whales have been targeting a price range of $160 to $520 for Eli Lilly over the last 3 months.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 6:16 pm

AAWH

AYRWF

CCHWF

CRLBF

CURLF

GTBIF

JUSHF

TRSSF

TRUL

VRNOF

Analysts have reasonable expectations for the ten largest MSOs, including Curaleaf, Green Thumb, Verano, Trulieve, Cresco, TerrAsced, Columbia, Ascend, Jushi, and AYR, leaving room for upside surprises. Revenue and EBITDA margin assumptions for 2023 and 2024 are not overly aggressive, with current estimates suggesting potential for growth.

Portfolio Pulse from Viridian Capital Advisors

June 05, 2023 | 6:03 pm

CHRW

In the last 3 months, 7 analysts have offered 12-month price targets for C.H. Robinson Worldwide (NASDAQ:CHRW), with an average price target of $86.0, up 0.47% from the previous average of $85.60. The company has received 3 indifferent and 4 somewhat bearish ratings.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 6:02 pm

CSTL

Castle Biosciences (NASDAQ:CSTL) has received 1 bullish and 6 somewhat bullish ratings from analysts in the last quarter. The average 12-month price target is $35.14, representing a 13.87% decrease from the previous average of $40.80.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 6:02 pm

GDDY

RBC Capital Markets analyst Brad Erickson initiated coverage on GoDaddy Inc (NYSE:GDDY) with a Sector Perform rating and a price target of $80. Erickson is bullish on GDDY's core business, citing its buyback program as positive. However, he sees GDDY's lower-quality GUI and lack of scalability as concerns.

Portfolio Pulse from Lekha Gupta

June 05, 2023 | 6:02 pm

PBR

A whale has taken a bearish stance on Petrobras Brasileiro (NYSE:PBR), with 60% of recent unusual options activity being bearish. Whales have been targeting a price range of $8.0 to $15.0 for the company over the last 3 months. Goldman Sachs maintains a Neutral rating with a price target of $12.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 6:02 pm

DAWN

Analysts have provided ratings for Day One Biopharmaceutical (NASDAQ:DAWN) in the last quarter, with 6 bullish, 1 somewhat bullish, and 1 somewhat bearish. The average 12-month price target is $38.75, a 9.36% decrease from the previous average of $42.75.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 6:02 pm

LEN

A whale investor has taken a bearish stance on Lennar (NYSE:LEN), with 70% of detected trades being bearish. Whales have been targeting a price range of $110 to $115 for Lennar over the last 3 months. Deutsche Bank downgraded Lennar to Sell with a price target of $105, while Barclays maintained their Overweight rating with a price target of $135.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 6:01 pm

CMA

Over the past 3 months, 15 analysts have published their opinion on Comerica (NYSE:CMA) stock, with an average 12-month price target of $56.22, a decrease of 26.55% from the previous average of $76.54.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 6:01 pm